Related Experiment Video
Updated: Feb 28, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
G1405 Ribosomal Methyltransferase-Driven Antibacterial Resistance Affects the 4,5-Disubstituted-2-deoxystreptamine
Sven N Hobbie1, Andrea Vasella2, Erik C Böttger1
1Institute of Medical Microbiology, Universität Zürich, Gloriastrasse 30, Zürich CH-8006, Switzerland.
Abstract:
The 4,5-disubstituted-2-deoxystreptamine (DOS) aminoglycosides (AGAs) and the 4-monosubstituted DOS AGA apramycin have long been known not to be affected by N7 methylation of the 16S rRNA base G1405, a critical mechanism of aminoglycoside resistance caused by ribosomal methyltransferases (RMTases). This puts the 4,5-AGAs and apramycin in a class apart from the 4,6-AGAs, whose action is blocked by RMTase-mediated G1405 N7 methylation and has rendered them attractive candidates for modification in drug-discovery campaigns. Contrary to this common perception, we reveal that multiple modifications of the 4,5-AGAs result in compounds whose minimum inhibitory concentrations are affected by G1405 N7 ribosomal methyltransferases. We argue that the combination of destabilization of the drug-ribosome complex caused by drug modification and G1405 N7 methylation, each of which alone may be insufficient to negatively impact activity, can result in reduced antibacterial activity. In contrast, AGA modifications that enhance affinity for the drug binding pocket will afford compounds that are not susceptible to G1405 RMTase activity, as is found for propylamycin and the apralogs. Future antibiotic discovery campaigns based on 4,5-AGAs and apramycin should take these findings into account.
Insights
Modified aminoglycosides (AGAs) can be affected by ribosomal methyltransferases, contrary to previous beliefs. Drug modifications and methylation can reduce antibacterial activity, impacting future antibiotic discovery.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Molecular Biology
Background:
- Aminoglycosides (AGAs) are antibiotics targeting bacterial ribosomes.
- 4,5-disubstituted-2-deoxystreptamine (DOS) AGAs and apramycin were thought resistant to ribosomal methyltransferase (RMTase)-mediated G1405 N7 methylation.
- This resistance mechanism is a key factor in aminoglycoside resistance.
Purpose of the Study:
- To investigate the impact of modifications on 4,5-DOS AGAs and apramycin activity in the presence of RMTases.
- To challenge the established understanding of resistance mechanisms for these AGA classes.
- To guide future antibiotic discovery efforts.
Main Methods:
- Synthesis of modified 4,5-DOS AGAs.
- Determination of minimum inhibitory concentrations (MICs).
- Assessment of susceptibility to G1405 N7 ribosomal methyltransferases.
Main Results:
- Contrary to common perception, modified 4,5-DOS AGAs showed reduced activity influenced by G1405 N7 RMTases.
- Combined effects of drug modification and G1405 N7 methylation can decrease antibacterial efficacy.
- Modifications enhancing drug-ribosome binding affinity, like in propylamycin and apralogs, confer resistance to RMTase activity.
Conclusions:
- The perceived resistance of 4,5-DOS AGAs and apramycin to RMTase-mediated G1405 N7 methylation is not absolute, especially with drug modifications.
- Drug modifications can create synergistic effects with methylation, leading to reduced antibiotic activity.
- Future antibiotic discovery should consider these drug-ribosome-RMTase interactions for designing effective compounds.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
06:18Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
Published on: April 26, 2019
Related Concept Videos
Development of Antibiotic Resistance
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Coordination of Gene Expression Processes in Bacteria